BioLife Solutions, Inc. Available-for-sale Securities, Gross Unrealized Loss
BioLife Solutions, Inc. (BLFS) reported Available-for-sale Securities, Gross Unrealized Loss of $451 for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2017-03-15
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2015-12-31 was $1.05K.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2015-03-31 was -$949.00.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized loss for fiscal 2015 was $451.00.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized loss for fiscal 2014 was -$6.45K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 9 month | Available-for-sale Securities, Gross Unrealized Loss 12 month | Available-for-sale Securities, Gross Unrealized Loss 12 month as first filed |
|---|---|---|---|---|
| 2015-12-31 | $1.05K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $451.00 10-K · filed 2017-03-15 | -$451.00 10-K · filed 2016-02-25 | |
| 2015-09-30 | -$601.00 10-Q · filed 2015-11-16 | |||
| 2015-03-31 | -$949.00 10-Q · filed 2015-05-07 | |||
| 2014-12-31 | -$6.45K 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |